‘Clinical significance’
-Deficiency in cortistatin could be further examined as a potential biomarker of susceptibility or poor-prognosis of developing severe hepatic fibrosis and cirrhosis. -Cortistatin-based therapies could serve for treating chronic hepatic disorders of different aetiologies to reduce disease severity and mortality.